A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
NCT ID: NCT01026142
Last Updated: 2018-08-14
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
452 participants
INTERVENTIONAL
2010-01-26
2017-08-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study of Perjeta (Pertuzumab) in Combination With Herceptin (Trastuzumab) in Participants With Metastatic Breast Cancer
NCT01674062
A Study of Pertuzumab in Participants With Metastatic Breast Cancer
NCT02491892
A Study of Pertuzumab in Combination With Trastuzumab Plus an Aromatase Inhibitor in Participants With Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive and Hormone Receptor-Positive Advanced Breast Cancer
NCT01491737
A Study to Assess Efficacy and Safety of Pertuzumab Given in Combination With Trastuzumab and Vinorelbine in Participants With Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor (HER) 2-Positive Breast Cancer
NCT01565083
Combination Chemotherapy With Trastuzumab in Treating Women With Metastatic Breast Cancer
NCT00036868
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
A: Capecitabine + Trastuzumab
Capecitabine
1250 mg/m2 po twice daily for 14 days every 3 weeks
Trastuzumab
8 mg/kg iv loading, then 6 mg/kg iv every 3 weeks
B: Capecitabine + Trastuzumab + Pertuzumab
Capecitabine
1000 mg/m2 po twice daily for 14 days every 3 weeks
Pertuzumab
840 mg iv loading, then 420 mg iv every 3 weeks
Trastuzumab
8 mg/kg iv loading, then 6 mg/kg iv every 3 weeks
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Capecitabine
1000 mg/m2 po twice daily for 14 days every 3 weeks
Capecitabine
1250 mg/m2 po twice daily for 14 days every 3 weeks
Pertuzumab
840 mg iv loading, then 420 mg iv every 3 weeks
Trastuzumab
8 mg/kg iv loading, then 6 mg/kg iv every 3 weeks
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Metastatic HER2 positive breast cancer
* Eastern Cooperative Oncology Group (ECOG) performance status 0 or 1
* Disease progression during or following trastuzumab-based therapy for 1st line metastatic breast cancer (trastuzumab must have been part of the last prior treatment regimen)
* Prior treatment with taxane-containing regimen
* Left ventricular ejection fraction (LVEF) \>/=50 percent
* For women of childbearing potential agreement to use highly effective non-hormonal form of contraception or two effective forms of non-hormonal contraception by patient and/or partner. Contraception must continue for duration of study treatment and for at least 6 months after last dose of study drug treatment
Exclusion Criteria
* Concurrent treatment with other experimental drug
* Concurrent immunotherapy or anticancer hormonal therapy
* Serious concurrent disease (e.g. active infection, uncontrolled hypertension, cardiovascular disease)
* Central nervous system (CNS) metastases, which are not well controlled
* History of exposure to anthracycline cumulative dose equivalent to 360mg/m2
* History of congestive heart failure of any New York Heart Association criteria, or serious cardiac arrhythmia requiring treatment
* History of myocardial infarction within 6 months prior to randomization
* History of LVEF decline to below 50% during or after prior trastuzumab therapy or other cardiac toxicity during previous trastuzumab treatment that necessitated discontinuation of trastuzumab
* History of another cancer which could affect compliance or result interpretation
* Inadequate organ function
* Pregnant or breastfeeding women
* life expectancy \< 12 weeks
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fundación Investigar
Buenos Aires, , Argentina
Hospital Britanico; Oncologia
Buenos Aires, , Argentina
Instituto FIDES
La Plata, , Argentina
Instituto de Investigaciones Clínicas Quilmes
Quilmes, , Argentina
Instituto de Oncología de Rosario
Rosario, , Argentina
ISIS Clinica Especializada
Santa Fe, , Argentina
A.Ö. Landesschwerpunktkrankenhaus Krems; Abtl. F. Innere Med.
Krems, , Austria
Landeskrankenhaus Rankweil; Interne E
Rankweil, , Austria
Lkh Salzburg - Univ. Klinikum Salzburg; Iii. Medizinische Abt.
Salzburg, , Austria
Medizinische Universität Wien; Univ.Klinik für Innere Medizin I - Abt. für Onkologie
Vienna, , Austria
Imeldaziekenhuis
Bonheiden, , Belgium
AZ KLINA
Brasschaat, , Belgium
UZ Brussel
Brussels, , Belgium
GHdC Site Notre Dame
Charleroi, , Belgium
CH Jolimont - Lobbes (Jolimont)
Haine-Saint-Paul, , Belgium
Jessa Zkh (Campus Virga Jesse)
Hasselt, , Belgium
AZ Groeninge
Kortrijk, , Belgium
CHU Sart-Tilman
Liège, , Belgium
Clinique Saint-Joseph
Liège, , Belgium
Clinique Ste-Elisabeth
Namur, , Belgium
AZ Nikolaas (Lodewijk)
Sint-Niklaas, , Belgium
Oncologia Sul Capixaba Servicos Medicos - Oncosul
Cachoeiro de Itapemirim, Espírito Santo, Brazil
Hospital Sao Lucas - PUCRS
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Perola Byington
São Paulo, São Paulo, Brazil
Hospital A. C. Camargo; Oncologia
São Paulo, São Paulo, Brazil
Centro Oncológico de Mogi das Cruzes
São Paulo- SP, São Paulo, Brazil
Durham Regional Cancer Centre
Oshawa, Ontario, Canada
Humber River Hospital
Toronto, Ontario, Canada
University Health Network; Princess Margaret Hospital; Medical Oncology Dept
Toronto, Ontario, Canada
Uni Hospital For Tumours; Dept of Medical Oncology
Zagreb, , Croatia
Masarykuv onkologicky ustav; Oncology II
Brno, , Czechia
University Hospital; Oncology and Radiotherapy
Hradec Králové, , Czechia
Fakultni Poliklinika Vseobecne Fakultni Niemocnice; Onkologicka Klinika
Prague, , Czechia
Lekarske Fakulty Univerzity Karlovy Fakultni Nemocnice Na Bulovce; Ustav Radiacni Onkologie
Prague, , Czechia
North Estonia Medical Centre Foundation; Oncology Centre
Tallinn, , Estonia
Tartu University Hospital; Clinic of Hematology and Oncology
Tartu, , Estonia
C.H. Du Pays D'aix En Provence Service du Dr Blanc
Aix-en-Provence, , France
Centre Oncologie Du Pays Basque
Bayonne, , France
Centre Hospitalier Fleyriat; Oncologie/Hematologie
Bourg-en-Bresse, , France
CHU Henri Mondor; Service d'Oncologie Medicale
Créteil, , France
Centre Georges Francois Leclerc; Oncologie 3
Dijon, , France
Centre Leon Berard; Oncologie Genetique
Lyon, , France
Centre Antoine Lacassagne; Hopital De Jour A2
Nice, , France
Institut Curie; Oncologie Medicale
Paris, , France
Hopital Saint Antoine; Sce Oncologie
Paris, , France
Institut Jean Godinot; Oncologie Medicale
Reims, , France
Centre Henri Becquerel; Oncologie Medicale
Rouen, , France
Centre Rene Huguenin; CONSULT SPECIALISEES
Saint-Cloud, , France
Hopital Hautepierre; Hematologie Oncologie
Strasbourg, , France
Institut Claudius Regaud; Departement Oncologie Medicale
Toulouse, , France
Clinique Pasteur; Oncologie Medicale
Toulouse, , France
CAMPUS CHARITÉ MITTE; Tagesklinik für Onkologie u.Hämatologie
Berlin, , Germany
Klinikum Sindelfinden Boblingen
Böblingen, , Germany
Klinikum Bremen-Mitte gGmbH; Frauenklinik
Bremen, , Germany
St. Elisabeth Krankenhaus Köln GmbH; Gynäkologie und Geburtshilfe
Cologne, , Germany
Klinikum Darmstadt GmbH; Med. Klinik V; Onkologie & Hämatologie
Darmstadt, , Germany
Klinikum Dortmund gGmbH Klinikzentrum Mitte
Dortmund, , Germany
Universitätsklinikum Essen; Zentrum Für Frauenheilkunde
Essen, , Germany
Klinikum Frankfurt Höchst GmbH; Klinik für Gynäkologie und Geburtshilfe
Frankfurt, , Germany
Klinik Fulda, Medizinisches Versorgungszentrum Osthessen GmbH
Fulda, , Germany
Universitätsklinikum Hamburg-Eppendorf; Zentrum für operative Medizin Klinik für Gynäkologie
Hamburg, , Germany
HOPA MVZ GmbH
Hamburg, , Germany
Diakovere Henriettenstift, Frauenklinik
Hanover, , Germany
Medizinische Hochschule Zentrum Frauenheilkunde Abt.Gynäkologische Onkologie
Hanover, , Germany
ViDia Christliche Kliniken Karlsruhe, Vincentius-Diakonissen-Kliniken gAG; Frauenklinik
Karlsruhe, , Germany
Systemedic Frauenarzte Pruener Gang
Kiel, , Germany
Institut für Versorgungsforschung in der Onkologie GbR Koblenz
Koblenz, , Germany
Universitätsklinikum Schleswig-Holstein / Campus Lübeck; Klinik für Frauenheilkunde und Geburtshilfe
Lübeck, , Germany
St. Vincenz-Elisabeth-Hospital; Katholisches Klinikum Mainz
Mainz, , Germany
Klinikum rechts der Isar der TU München; Frauenklinik & Poliklinik
München, , Germany
Universitätsklinikum Münster; Klinik für Frauenheilkunde und Geburtshilfe
Münster, , Germany
St. Josefs Klinik; Medizinische Klinik
Offenburg, , Germany
Praxis für Onkologie und Hämatologie
Recklinghausen, , Germany
Johanniter Klinik
Stendal, , Germany
Klinikum Mutterhaus der Borromaeerinnen gGmbH; Haematologie/Onkologie
Trier, , Germany
GRN Klinik Weinheim
Weinheim, , Germany
Queen Mary Hospital; Surgery
Hong Kong, , Hong Kong
Queen Elizabeth Hospital; Clinical Oncology
Hong Kong, , Hong Kong
Tuen Mun Hospital; Clinical Oncology
Hong Kong, , Hong Kong
Ogyi, Orszagos Gyogyszereszeti Intezet
Budapest, , Hungary
Semmelweis Egyetem Onkologiai Központ
Budapest, , Hungary
Fövárosi Önkormányzat Bajcsy-Zsilinszky Kórház; Onkológiai Osztály
Budapest, , Hungary
Orszagos Onkologiai Intezet; B Belgyogyaszati Osztaly
Budapest, , Hungary
Semmelweis Egyetem Aok; Iii.Sz. Belgyogyaszati Klinika
Budapest, , Hungary
Municipal Hospital of Uzsoki Utca; Centre of Oncoradiology
Budapest, , Hungary
Hospital of Aladar Petz; Dept of Oncoradiology
Győr, , Hungary
Békés Megyei Pándy Kálmán Kórház; Onkologiai tanszek
Gyula, , Hungary
Kaposi Mor County Hospital; Dept. of Oncology
Kaposvár, , Hungary
Borsod-Abauj-Zemplen Megyei Korhaz Es Egyetemi Oktato Korhaz; Onkologiai Osztaly
Miskolc, , Hungary
Josa Andras Korhaz; Dept of Oncoradiology
Nyíregyháza, , Hungary
Pécsi Tudományegyetem Áok; Onkoterapias Intezet
Pécs, , Hungary
Szegedi Tudomanyegyetem, AOK, Szent-Gyorgyi Albert Klinikai Kozpont, Onkoterapias Klinika
Szeged, , Hungary
Fejér Megyei Szent György Kórház; Onkológiai Osztály
Székesfehérvár, , Hungary
Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház; Onkológiai Osztály
Szolnok, , Hungary
Istituto Tumori Fondazione Pascale; Endocrinologia Oncologica
Napoli, Campania, Italy
Az. Osp. S. Orsola Malpighi; Istituto Di Oncologia Seragnoli
Bologna, Emilia-Romagna, Italy
Ospedale Cervesi di Cattolica ; Unità Operativa di Oncologia ed Oncoematologia
Cattalica, Emilia-Romagna, Italy
AUSL Cesena; Servizio di Oncologia
Cesena, Emilia-Romagna, Italy
Ausl Ravenna-Osp.Infermi; Day Hospital Oncologia Medica
Faenza, Emilia-Romagna, Italy
Ospedale Umberto I ASL di Ravenna Presidio Ospedaliero di Lugo
Lugo, Emilia-Romagna, Italy
Azienda USL di Ravenna; Unità Operativa di Oncologia Medica
Ravenna, Emilia-Romagna, Italy
Ospedale Infermi Di Rimini; Unità Operativa di Oncologia e Oncoematologia
Rimini, Emilia-Romagna, Italy
Istituto Regina Elena; Oncologia Medica A
Rome, Lazio, Italy
Uni Cattolica Policlinico Gemelli; Oncologia Medica Ist. Medicina Interna
Rome, Lazio, Italy
Asst Papa Giovanni XXIII; Oncologia Medica
Bergamo, Lombardy, Italy
ASST DI CREMONA; Dipartimento Aziendale Oncologico
Cremona, Lombardy, Italy
Ospedale Mater Salutis; Dept of Oncology
Legnago, Lombardy, Italy
ASST DI MONZA; Oncologia Medica
Monza, Lombardy, Italy
IRCCS Fondazione Maugeri; Oncologia Medica II
Pavia, Lombardy, Italy
ASST LARIANA; Oncologia
S. Fermo Della Battaglia (CO), Lombardy, Italy
A.O. Città della Salute e della Scienza - Presidio Molinette; divisione oncologia medica
Turin, Piedmont, Italy
Ospedale Civile; Oncologia Medica
Sassari, Sardinia, Italy
ARNAS-Ospedale Civico Maurizio Ascoli; Unità Operativa di Oncologia Medica
Palermo, Sicily, Italy
Azienda ospedaliero-universitaria careggi, Sezione di radioterapia del dipartimento di fisiopatolo
Florence, Tuscany, Italy
A.O. Universitaria Pisana; Oncologia
Pisa, Tuscany, Italy
Oaxaca Site Management Organization
Oaxaca City, , Mexico
Centro Oncológico Estatal; ISSSEMYM Oncología
Toluca, , Mexico
Vu Medisch Centrum; Afdeling Maag-, Darm- En Leverziekte
Amsterdam, , Netherlands
Hospital Nacional Carlos Alberto Seguin Escobedo-Essalud; Oncology & Haemathology
Arequipa, , Peru
Hospital Nacional Edgardo Rebagliati Martins
Jesus Maria, , Peru
Clinica Anglo Americana - Centro de Investigacion Oncologia CAA
Lima, , Peru
Unidad de Investigacion Oncologia Clinica - Piura; Unidad de Oncología Clínica
Piura, , Peru
Szpital Specjalistyczny Podkarpacki Ośrodek Onkologiczny
Brzozów, , Poland
Wojewodzki Szpital Zespolony; Oddzial Chemioterapii
Elblag, , Poland
Wojewodzkie Centrum Onkologii
Gdansk, , Poland
COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej
Lublin, , Poland
Wojewodzki Sziptal Specjalistyczny Im. Janusza Korczaka; Oddzial Onkologiczny, Oddzial Chemioterapii
Słupsk, , Poland
Spitalul Clinic Sf. Maria; Departmental De Oncologie
Bucharest, , Romania
Institut of Oncology Al. Trestioreanu Bucharest; Oncology Department
Bucharest, , Romania
Institute Of Oncology Bucharest; Medical Oncology
Bucharest, , Romania
Cluj Clinical County Hospital; Oncology Dept
Cluj-Napoca, , Romania
Prof. Dr. I. Chiricuta Institute of Oncology
Cluj-Napoca, , Romania
Medisprof SRL
Cluj-Napoca, , Romania
Municipal Clinical Hospital Filantropia; Oncology
Craiova, , Romania
Euroclinic Center of Oncology SRL
Iași, , Romania
Regional Oncology Hospital of Krasnodar; Oncology
Krasnodar, , Russia
Blokhin Cancer Research Center; Combined Treatment
Moscow, , Russia
Semashko Central Clinical Hospital; Dept of Chemotherapy
Moscow, , Russia
GUZ Perm Region Oncology Dispensary
Perm, , Russia
S.-Peterburg Pavlov State Medical University ; Haematology
Saint Petersburg, , Russia
Saint-Petersburg City Clinical Oncology Dispensary
Saint Petersburg, , Russia
SBI of Healthcare of Stavropol region Stavropol Regional Clinical Oncology Dispensary
Stavropol, , Russia
Severance Hospital
Seoul, , South Korea
Seoul National University Hosp; Dept Internal Med Hem Onc
Seoul, , South Korea
Asan Medical Center, Uni Ulsan Collegemedicine; Dept.Internal Medicine / Divisionhematology/Oncology
Seoul, , South Korea
Korea University Guro Hospital; Oncology
Seoul, , South Korea
Hospital Clinica Benidorm
Benidorm, Alicante, Spain
Complejo Hospitalario Torrecardenas; Servicio de Oncologia
Almería, Almeria, Spain
Consorci Hospitalari de Terrassa
Terrassa, Barcelona, Spain
Hospital Provincial de Castellón
Castellon, Castellon, Spain
Fundacion Hospital de Alcorcon; Servicio de Oncologia
Alcorcón, Madrid, Spain
Hospital Universitario Puerta de Hierro
Majadahonda, Madrid, Spain
Hospital Universitario de Canarias;servicio de Oncologia
San Cristóbal de La Laguna, Tenerife, Spain
Complejo Hospitalario Nuestra Señora de la Candelaria; Servicio de Oncologia
Santa Cruz de Tenerife, Tenerife, Spain
Hospital de Sagunto; Servicio de Oncologia
Sagunto, Valencia, Spain
Hospital de Basurto; Servicio de Oncologia
Bilbao, Vizcaya, Spain
Hospital Clinic i Provincial; Servicio de Farmacia
Barcelona, , Spain
Institut Catala d Oncologia Hospital Duran i Reynals
Barcelona, , Spain
Hospital Juan Ramon Jimenez;Servicio de Oncologia
Huelva, , Spain
Complejo Asistencial Universitario de Leon; Servicio de Oncologia
León, , Spain
Hospital General Universitario Gregorio Marañon; Servicio de Oncologia
Madrid, , Spain
Hospital Ruber Internacional;Servicio de Oncologia
Madrid, , Spain
Fundacion Jimenez Diaz; Servicio de Oncologia
Madrid, , Spain
Hospital La Paz
Madrid, , Spain
Complejo Hospitalario de Pontevedra; Servicio de Oncologia
Pontevedra, , Spain
Hospital Clinico Universitario de Salamanca; Servicio de Oncologia
Salamanca, , Spain
Hospital Universitario Virgen Macarena; Servicio de Oncologia
Seville, , Spain
Hospital Universitario Virgen del Rocio
Seville, , Spain
Hospital Univ. Nuestra Señora de Valme;
Seville, , Spain
Hospital Sant Pau i Santa Tecla
Tarragona, , Spain
Complejo Hospitalario de Toledo- H. Virgen de la Salud; Servicio de Oncologia
Toledo, , Spain
Instituto Valenciano Oncologia; Oncologia Medica
Valencia, , Spain
Hospital Clinico Universitario de Valencia; Servicio de Onco-hematologia
Valencia, , Spain
Hospital Universitario la Fe; Servicio de Oncologia
Valencia, , Spain
Hospital Universitario Miguel Servet
Zaragoza, , Spain
Phramongkutklao Hospital;Dept Surgery/Surgical Oncology Unit
Bangkok, , Thailand
Ramathibodi Hospital; Department of Surgery/Breast and Endocrine Unit
Bangkok, , Thailand
Maharaj Nakorn Chiang Mai Hospital; Department of Surgery/Head Neck and Breast Unit; Clinical Trial
Chiang Mai, , Thailand
Srinagarind Hospital; Department of Surgery
Khon Kaen, , Thailand
Songklanagarind Hospital; Department of Surgery
Songkhla, , Thailand
Royal Bournemouth General Hospital; Oncology
Bournemouth, , United Kingdom
Velindre Cancer Centre; Oncology Dept
Cardiff, , United Kingdom
Broomfield Hospital
Chelmsford, , United Kingdom
University Hospital of North Durham; Oncology
Durham, , United Kingdom
Beatson West of Scotland Cancer Centre
Glasgow, , United Kingdom
Christie Hospital; Breast Cancer Research Office
Manchester, , United Kingdom
Nottingham City Hospital
Nottingham, , United Kingdom
Peterborough City Hospital, Edith Cavell Campus; Oncology Department
Peterborough, , United Kingdom
Great Western Hospital; Clinical Oncology
Swindon, , United Kingdom
Royal Cornwall Hospital; Dept of Clinical Oncology
Truro, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2008-006801-17
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
MO22324
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.